Hims & Hers Health HIMS

Hims & Hers Health FY 2025: revenue $2.3B, up 59%; diluted EPS $0.51

Form
10-K
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers Hims & Hers Health reported for the year ended Dec 31, 2025, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Revenue$2.3B+59% from $1.5B in FY 202410-K income statement, on EDGAR
  2. Net income$128.4M+2% from $126.0M in FY 202410-K income statement, on EDGAR
  3. Diluted EPS$0.51−4% from $0.53 in FY 202410-K income statement, on EDGAR
  4. Cash and cash equivalents$228.6M+4% from $220.6M in FY 2024Cash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
  5. Cash from operations$300.0M+19% from $251.1M in FY 202410-K cash flow statement, on EDGAR

Every year in the financial tables

Get an email when Hims & Hers Health files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8011 and related industry codes: the same peer list as the financial tables.